Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

BDTX US Equity

Black Diamond Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1701541 · FY ends Dec 31
$2.19
+0.13 (+6.31%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-08

Every row is a filed document, checked against its EDGAR index.